The effect of medical and urologic disorders on the survival of patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide

INTRODUCTION: Androgenic deprivation therapies have been linked to the development of metabolic syndrome (MS) and cardiovascular diseases, which may lead to a poorer survival in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC). We aimed to analyze whether some cardiovascular or...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano Domingo, Juan José, Alonso Gordoa, Teresa, Lorca Álvaro, Javier, Molina-Cerrillo, Javier, Barquín García, Arantzazu, Martínez Sáez, Olga, Burgos Revilla, Javier, Carrato, Alfredo, Álvarez Rodríguez, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451255/
https://www.ncbi.nlm.nih.gov/pubmed/34552666
http://dx.doi.org/10.1177/17562872211043341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451255/
https://www.ncbi.nlm.nih.gov/pubmed/34552666
http://dx.doi.org/10.1177/17562872211043341

Ejemplares similares